EFS in patients. EFS is shown during (A) second-line chemotherapy; and (B) after allogeneic BM transplantation. Kaplan-Meier plots show prognostically different groups as defined by a threshold of 0.1%NPM1/ABL expression at different intervals after start of therapy.